Oslo University Hospital
Clinical trials sponsored by Oslo University Hospital, explained in plain language.
-
Experimental cancer drug trial halted early
Disease control TerminatedThis study tested an experimental drug called BM7PE in people with advanced colorectal cancer that had stopped responding to standard chemotherapy. The goal was to find a safe dose and see if it could help patients live longer. The trial was terminated early, so results are limit…
Phase: PHASE1, PHASE2 • Sponsor: Oslo University Hospital • Aim: Disease control
Last updated May 17, 2026 03:24 UTC
-
Home BP checks for kidney transplant patients: a small study that stopped early
Disease control TerminatedThis study looked at whether having kidney transplant recipients check their blood pressure at home helps lower it better than standard care. The trial planned to include many patients but was stopped early after enrolling only 21 people. Researchers measured blood pressure and m…
Phase: NA • Sponsor: Oslo University Hospital • Aim: Disease control
Last updated May 12, 2026 13:42 UTC
-
Blood tests may predict lung cancer drug success
Knowledge-focused TerminatedThis study monitored drug levels in the blood of 80 patients with advanced non-small cell lung cancer who were receiving pembrolizumab (immunotherapy) alone or with chemotherapy. Researchers wanted to see if drug levels were linked to how well the cancer responded or if side effe…
Sponsor: Oslo University Hospital • Aim: Knowledge-focused
Last updated May 17, 2026 03:27 UTC
-
Liquid biopsy study halted: could blood tests guide cancer care?
Knowledge-focused TerminatedThis study looked at whether a simple blood test (called a liquid biopsy) could help doctors make better treatment decisions for people with advanced cancers of the colon, pancreas, or bile ducts. Researchers planned to enroll about 16 participants to see if the test results woul…
Sponsor: Oslo University Hospital • Aim: Knowledge-focused
Last updated May 11, 2026 20:47 UTC